Tag: CAS
Interventional News Issue 96—November 2024 US Edition
Interventional News 96 Highlights:
New research finds that genicular artery embolization (GAE) has a lasting benefit of up to two years for moderate to...
Interventional News Issue 96—November 2024 Edition
Interventional News 96 Highlights:
New research finds that genicular artery embolization (GAE) has a lasting benefit of up to two years for moderate to...
LINC 2024: C-GUARDIANS data represent lowest event rates in published trials...
New data from the C-GUARDIANS pivotal investigational device exemption (IDE) trial support consideration of carotid artery stenting (CAS) with the CGuard embolic prevention stent...
CMS carotid stenting coverage expansion initiates concern over standard-of-care requirements and...
Dated 11 October 2023, the US Centers for Medicare & Medicaid Services (CMS) recently finalised its decision regarding National Coverage Determination (NCD) 20.7 for...
First-time data releases at LINC 2023 “confirm” Roadsaver carotid stent safety...
Presenting first-time data from large multicentre European studies at this year's Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Arne Schwindt (St Franziskus...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
New Vascular Ultrasound Registry launched, will initial focus on carotid artery...
The registry will combine noninvasive, vascular ultrasound testing data with vascular treatment and outcomes data, making it possible to analyse the relationships between diagnosis...
Twelve-month PARADIGM study data demonstrate benefit of CGuard Embolic Prevention System...
InspireMD has announced 12-month follow up data from PARADIGM-101 study of the CGuard Embolic Prevention System (EPS), which were presented at the Transcatheter Cardiovascular...
